COVID-19 project

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2] Sahar Memar Montazerin, M.D.[3]

Overview

Coronavirus, named due to the "crown" like appearance of its surface projections, was first isolated from chickens in 1937. The etiological agent, a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), named for the similarity of its symptoms to those induced by the severe acute respiratory syndrome, causing coronavirus disease 2019 (COVID-19), is a virus identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China. On March 12, 2020 the World Health Organization declared the COVID-19 outbreak a pandemic.

Statement of Need

As the Covid-19 pandemic has spread all over the globe, there has been growing reports and studies demonstrating its catastrophic effects on different organ systems. As medical professionals encountering a large number of cases on a daily basis, we feel the necessity of gathering all the information in a database where we can refer to while managing patients affected by COVID-19.

The COVID-19 projects is established to achieve the following goals:

• Gather all the evidence-based information regarding COVID-19 in one database to be used as an educational source for medical professionals.
• Provide information on how COVID-19 affects the physiology of different organ systems to optimize patient care.
• Provide information on different clinical manifestations of COVID-19 as well as possible evidence-based approaches for the management of those conditions.
• Provide information on latest clinical trials investigating strategies to treat or prevent COVID-19.